Please login to the form below
Boehringer Ingelheim
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.
Break Over-Reliance
by Boehringer Ingelheim and Action for Pulmonary Fibrosis. with support from 11 London (supported by AVT). ... Talking PF, Mini Talks and Live Q&As About Lungs, Life and Keeping Strong - by Boehringer Ingelheim and Action for Pulmonary Fibrosis.
Live Life with ITP
by Boehringer Ingelheim and Action for Pulmonary Fibrosis. with support from 11 London (supported by AVT). ... Talking PF, Mini Talks and Live Q&As About Lungs, Life and Keeping Strong - by Boehringer Ingelheim and Action for Pulmonary Fibrosis.
Novo Nordisk to buy Dicerna Pharmaceuticals for $3.3bn
Its platform has attracted attention from several pharma companies and Dicerna has ongoing partnerships with Roche, Eli Lilly, Alexion and Boehringer Ingelheim.
Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
The FDA has approved Boehringer’s Cyltezo (adalimumab-adbm) as ‘interchangeable’ with Humira (adalimumab) in a landmark ruling. ... The approval by the US Food and Drug Administration (FDA) of Boehringer Ingelheim's Cyltezo as an interchangeable
Christianna Gorin is appointed Health Practice Lead and Chief Strategy Officer, VMLY&R Health
Boehringer Ingelheim.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- ONS data reveals significant decrease in COVID-19 antibodies
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Eli Lilly to make bebtelovimab commercially available to US states from August
- ONS records a continued fall in UK COVID-19 infections
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- Lack of evidence for AstraZeneca’s COVID-19 vaccine says UK Department of Health
- NHS England outlines measures to boost capacity ahead of substantial winter pressures
- New research shows drug candidate may effectively treat antibiotic-resistant bacteria
- Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Roche shares new positive Ocrevus data for MS patients
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- bluebird bio reveals plans to launch two gene therapies
- NHS App to revolutionise digital health and care with major digital updates by 2023
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
